EELS (Ethical Economic Legal and Social) Article

Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?

• S J Bielinski
• J L St Sauver
• V L Roger

Management and return of incidental genomic findings in clinical trials

• C Ayuso
• J M Millan
• R Dal-Re

The potential impact of pharmacogenetic testing on medication adherence

• S B Haga
• N M A LaPointe

Informed consent in the context of pharmacogenomic research: ethical considerations

• H C Howard
• Y Joly
• J C Tardif

Ethical considerations in the collection of genetic data from critically ill patients: What do published studies reveal about potential directions for empirical ethics research?

• B D Freeman
• C R Kennedy
• T G Buchman

Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees

• R Dal-Ré
• I Luque
• J Lahuerta

Bidil: recontextualizing the race debate

• B Séguin
• B Hardy
• A S Daar

Ancillary risk information and pharmacogenetic tests: social and policy implications

• N B Henrikson
• W Burke
• D L Veenstra

I have forgotten ever having undergone heart surgery…

• A Palotás

Pharmacogenetics and ethical considerations: why care?

• L Marx-Stölting

Ethical problems in pharmacogenetic studies of psychiatric disorders

• A Serretti
• P Artioli

Pharmacogenetic research and data protection – challenges and solutions

• J Reischl
• M Schröder
• S Stürzebecher

Pharmacogenomics and regulatory decision making: an international perspective

• D L Mendrick
• C Brazell
• D Jacobson-Kram

The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies

• A Woelderink
• D Ibarreta
• E Rodriguez-Cerezo

Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?

• M W Foster
• R R Sharp

Stored tissue samples: through the confidentiality maze

• Y Joly
• B M Knoppers
• M T Nguyen

Pharmacogenomics in Japan

• M Tamaoki
• H Gushima
• K Tsutani

Pharmacogenomics in drug development: societal and technical aspects

• T Bartfai

Ethical, social and legal issues in pharmacogenomics

• D C Wertz

Pharmacogenetics: the ethical issues

• P Lipton